Archive
Back to homepage
77.4% ORR! Abbisko to present the updated clinical phase Ib data of Pimicotinib (ABSK021) at the 2023 ASCO Annual Meeting
SHANGHAI, May 28, 2023 /PRNewswire/ — Abbisko Therapeutics Co., Ltd. (“Abbisko Therapeutics” hereafter) today announced that the updated results of Phase Ib study of its CSF-1R inhibitor Pimicotinib (ABSK021) in treating patients with advanced tenosynovial giant cell tumor (“TGCT”), will
Read More
Credits roll on two weeks of unforgettable creations inspired by Campari, at 76th Festival de Cannes
CANNES, France, May 28, 2023 /PRNewswire/ — As an official partner to the 76th edition of the world-renowned Festival de Cannes, Campari, the icon of cocktail culture inspired through a series of events that celebrated the unforgettable creations of mixology
Read More
Big Data Expo 2023: Merging Digital Technology with Culture
GUIYANG, China, May 28, 2023 /PRNewswire/ — A news report by Huanqiu.com: The much-awaited Big Data Expo 2023, taking place from May 26th to 28th in Guiyang, presents an array of groundbreaking technological accomplishments that are redefining the nexus of
Read More